ArticleDrug safety2020

Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase.

Enriqueta Vallejo-Yagüe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.